Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Pacira BioSciences, Inc. PCRX

Full chart Compare
Set alert

Price alert · PCRX

All alert types
36.43 USD +0.01 (+0.03%)

At closeNov 6, 2026, 4:38 PM EST

36.43 0.00 0.00%

After hours · Nov 6, 4:38 PM ET

36.42 Day range 36.45
19.16 52-week range 36.43
YTD
+40.77%
1 year
+72.65%

Financial health

Altman Z-Score

2.80 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

7 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

B+3 / 5 overall

  • DCF 4
  • Return on Equity 3
  • Return on Assets 4
  • Debt / Equity 2
  • P/E 2
  • P/B 4

Valuation

P/E 162×
FY 2016: -31.7×FY 2017: -42.7×FY 2018: -3741×FY 2019: -168×FY 2020: 17.5×FY 2021: 63.3×FY 2022: 110×FY 2023: 37.1×FY 2024: -8.8×FY 2025: 162×
FY 2016 5y median 63.3× FY 2025
P/S 1.6×
FY 2016: 4.3×FY 2017: 6.3×FY 2018: 5.2×FY 2019: 4.5×FY 2020: 5.9×FY 2021: 4.9×FY 2022: 2.6×FY 2023: 2.3×FY 2024: 1.2×FY 2025: 1.6×
FY 2016 5y median 2.3× FY 2025
P/B 1.7×
FY 2016: 5.5×FY 2017: 6.5×FY 2018: 5.5×FY 2019: 5.3×FY 2020: 4.1×FY 2021: 3.6×FY 2022: 2.3×FY 2023: 1.8×FY 2024: 1.1×FY 2025: 1.7×
FY 2016 5y median 1.8× FY 2025
P/FCF 8.4×
FY 2016: 137×FY 2017: -1227×FY 2018: 51.2×FY 2019: 31.2×FY 2020: 65.1×FY 2021: 33.4×FY 2022: 15.3×FY 2023: 11.2×FY 2024: 4.9×FY 2025: 8.4×
FY 2016 5y median 11.2× FY 2025
EV/EBITDA 11.8×
FY 2016: -71.3×FY 2017: -193×FY 2018: 58.0×FY 2019: 70.1×FY 2020: 47.2×FY 2021: 28.1×FY 2022: 17.2×FY 2023: 12.9×FY 2024: 42.4×FY 2025: 11.8×
FY 2016 5y median 17.2× FY 2025
EV/Sales 2.0×
FY 2016: 4.6×FY 2017: 7.1×FY 2018: 5.7×FY 2019: 5.1×FY 2020: 7.0×FY 2021: 5.9×FY 2022: 3.6×FY 2023: 3.0×FY 2024: 1.8×FY 2025: 2.0×
FY 2016 5y median 3.0× FY 2025
FCF Yield 11.8%
FY 2016: 0.7%FY 2017: -0.1%FY 2018: 2.0%FY 2019: 3.2%FY 2020: 1.5%FY 2021: 3.0%FY 2022: 6.6%FY 2023: 8.9%FY 2024: 20.5%FY 2025: 11.8%
FY 2016 5y median 8.9% FY 2025

Profitability

Gross Margin 79.4%
FY 2016: 60.2%FY 2017: 69.3%FY 2018: 74.3%FY 2019: 74.7%FY 2020: 72.7%FY 2021: 74.1%FY 2022: 70.1%FY 2023: 72.6%FY 2024: 75.7%FY 2025: 79.4%
FY 2016 5y median 74.1% FY 2025
Operating Margin 4.6%
FY 2016: -11.6%FY 2017: -8.7%FY 2018: 4.7%FY 2019: 2.5%FY 2020: 10.8%FY 2021: 16.6%FY 2022: 9.0%FY 2023: 13.0%FY 2024: -10.5%FY 2025: 4.6%
FY 2016 5y median 9.0% FY 2025
Net Margin 1.0%
FY 2016: -13.7%FY 2017: -14.9%FY 2018: -0.1%FY 2019: -2.6%FY 2020: 33.9%FY 2021: 7.8%FY 2022: 2.4%FY 2023: 6.2%FY 2024: -14.2%FY 2025: 1.0%
FY 2016 5y median 2.4% FY 2025
ROE 1.0%
FY 2016: -17.3%FY 2017: -15.2%FY 2018: -0.1%FY 2019: -3.1%FY 2020: 23.5%FY 2021: 5.7%FY 2022: 2.1%FY 2023: 4.8%FY 2024: -12.8%FY 2025: 1.0%
FY 2016 5y median 2.1% FY 2025
ROIC 1.2%
FY 2016: -9.2%FY 2017: -4.4%FY 2018: 2.5%FY 2019: 1.4%FY 2020: 3.9%FY 2021: 3.5%FY 2022: 3.8%FY 2023: 4.0%FY 2024: -5.0%FY 2025: 1.2%
FY 2016 5y median 3.5% FY 2025
ROA 0.6%
FY 2016: -9.7%FY 2017: -6.8%FY 2018: -0.1%FY 2019: -1.3%FY 2020: 11.4%FY 2021: 2.0%FY 2022: 0.9%FY 2023: 2.7%FY 2024: -6.4%FY 2025: 0.6%
FY 2016 5y median 0.9% FY 2025

Growth (YoY)

Revenue 3.6%
FY 2016: 11.0%FY 2017: 3.7%FY 2018: 17.7%FY 2019: 24.8%FY 2020: 2.0%FY 2021: 26.0%FY 2022: 23.1%FY 2023: 1.2%FY 2024: 3.9%FY 2025: 3.6%
FY 2016 FY 2025
Operating Income 145.4%
FY 2016: -438.7%FY 2017: 22.1%FY 2018: 163.8%FY 2019: -34.2%FY 2020: 342.3%FY 2021: 94.0%FY 2022: -33.3%FY 2023: 46.1%FY 2024: -183.7%FY 2025: 145.4%
FY 2016 FY 2025
EPS (diluted) 107.4%
FY 2016: -2650.0%FY 2017: -4.9%FY 2018: 98.9%FY 2019: -2247.8%FY 2020: 1333.3%FY 2021: -72.4%FY 2022: -63.0%FY 2023: 161.8%FY 2024: -341.6%FY 2025: 107.4%
FY 2016 FY 2025
Free Cash Flow -23.5%
FY 2016: 171.2%FY 2017: -116.9%FY 2018: 2419.8%FY 2019: 75.7%FY 2020: -35.0%FY 2021: 103.5%FY 2022: 44.3%FY 2023: 21.1%FY 2024: 28.1%FY 2025: -23.5%
FY 2016 FY 2025

Financial Health

Current Ratio 4.5×
FY 2016: 5.4×FY 2017: 7.0×FY 2018: 7.9×FY 2019: 3.8×FY 2020: 2.6×FY 2021: 1.7×FY 2022: 3.4×FY 2023: 5.2×FY 2024: 2.4×FY 2025: 4.5×
FY 2016 5y median 3.4× FY 2025
Quick Ratio 3.3×
FY 2016: 4.7×FY 2017: 6.2×FY 2018: 7.1×FY 2019: 3.3×FY 2020: 2.3×FY 2021: 1.5×FY 2022: 2.7×FY 2023: 4.2×FY 2024: 2.0×FY 2025: 3.3×
FY 2016 5y median 2.7× FY 2025
Debt / Equity 0.7×
FY 2016: 0.5×FY 2017: 1.0×FY 2018: 0.9×FY 2019: 1.0×FY 2020: 0.9×FY 2021: 1.5×FY 2022: 1.0×FY 2023: 0.7×FY 2024: 0.8×FY 2025: 0.7×
FY 2016 5y median 0.8× FY 2025
Net Debt / EBITDA 2.4×
FY 2016: -4.1×FY 2017: -21.0×FY 2018: 4.8×FY 2019: 8.9×FY 2020: 6.9×FY 2021: 4.8×FY 2022: 4.7×FY 2023: 2.8×FY 2024: 12.4×FY 2025: 2.4×
FY 2016 5y median 4.7× FY 2025
Interest Coverage 2.3×
FY 2016: -4.5×FY 2017: -1.4×FY 2018: 0.7×FY 2019: 0.4×FY 2020: 1.8×FY 2021: 3.1×FY 2022: 1.7×FY 2023: 5.1×FY 2024: -4.4×FY 2025: 2.3×
FY 2016 5y median 2.3× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31